Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IRMD iRadimed	$56.69 -1.3%	$57.62	$42.34 ▼ $63.29	$720.81M	0.91	44,166 shs	30,893 shs
MDXG MiMedx Group	$6.42 -4.5%	$6.48	$5.47 ▼ $10.14	$948.25M	1.76	702,843 shs	669,822 shs
OFIX Orthofix Medical	$10.63 -2.0%	$11.17	$10.24 ▼ $20.73	$416.49M	0.8	288,239 shs	278,019 shs
SGHT Sight Sciences	$3.50 -1.1%	$3.80	$2.03 ▼ $8.45	$180.94M	2.47	207,279 shs	80,708 shs

Analysts Agree—These Gold Picks Outshine the Rest

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IRMD iRadimed	-1.32%	-1.53%	-3.01%	+9.50%	+22.76%
MDXG MiMedx Group	-4.46%	-3.60%	+8.81%	-3.82%	-13.94%
OFIX Orthofix Medical	-2.03%	-3.80%	+2.71%	-18.42%	-34.38%
SGHT Sight Sciences	-1.13%	+2.64%	-18.03%	+31.58%	-57.11%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
IRMD iRadimed	4.5167 of 5 stars	3.5	3.0	2.5	4.4	0.0	3.3	1.9
MDXG MiMedx Group	3.5694 of 5 stars	3.5	2.0	0.0	0.0	3.8	3.3	1.3
OFIX Orthofix Medical	2.9567 of 5 stars	3.5	1.0	0.0	0.0	2.1	3.3	1.3
SGHT Sight Sciences	1.5823 of 5 stars	2.1	2.0	0.0	0.0	1.8	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IRMD iRadimed	3.00	Buy	$72.00	27.01% Upside
MDXG MiMedx Group	3.00	Buy	$11.50	79.13% Upside
OFIX Orthofix Medical	3.00	Buy	$21.50	102.26% Upside
SGHT Sight Sciences	2.29	Hold	$3.93	12.38% Upside

Current Analyst Ratings Breakdown

Latest IRMD, OFIX, MDXG, and SGHT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/15/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$11.00
7/15/2025	SGHT Sight Sciences	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$3.00 ➝ $4.00
6/23/2025	OFIX Orthofix Medical	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$16.00
6/18/2025	SGHT Sight Sciences	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$3.50 ➝ $4.00
6/6/2025	OFIX Orthofix Medical	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
5/22/2025	SGHT Sight Sciences	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$3.20 ➝ $3.60
5/9/2025	SGHT Sight Sciences	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$2.50 ➝ $3.00

(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IRMD iRadimed	$73.24M	9.85	$1.58 per share	35.83	$6.85 per share	8.28
MDXG MiMedx Group	$348.88M	2.72	$0.33 per share	19.38	$1.31 per share	4.90
OFIX Orthofix Medical	$799.49M	0.52	N/A	N/A	$13.07 per share	0.81
SGHT Sight Sciences	$79.87M	2.27	N/A	N/A	$1.72 per share	2.03

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IRMD iRadimed	$19.23M	$1.55	36.57	28.35	N/A	26.33%	23.28%	20.59%	7/30/2025 (Estimated)
MDXG MiMedx Group	$42.42M	$0.27	23.78	20.06	N/A	11.40%	22.70%	16.77%	7/30/2025 (Estimated)
OFIX Orthofix Medical	-$126M	-$3.69	N/A	N/A	N/A	-17.78%	-28.15%	-16.51%	8/5/2025 (Estimated)
SGHT Sight Sciences	-$51.51M	-$0.98	N/A	N/A	N/A	-63.24%	-54.62%	-34.92%	7/30/2025 (Estimated)

Latest IRMD, OFIX, MDXG, and SGHT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	IRMD iRadimed	$0.45	N/A	N/A	N/A	N/A	N/A
8/7/2025	Q2 2025	SGHT Sight Sciences	-$0.25	N/A	N/A	N/A	$18.18 million	N/A
8/5/2025	Q2 2025	OFIX Orthofix Medical	$0.04	N/A	N/A	N/A	$196.89 million	N/A
7/30/2025	Q2 2025	MDXG MiMedx Group	$0.06	N/A	N/A	N/A	$90.79 million	N/A
5/8/2025	Q1 2025	SGHT Sight Sciences	-$0.29	-$0.28	+$0.01	-$0.28	$16.51 million	$17.51 million
4/30/2025	Q1 2025	MDXG MiMedx Group	$0.06	$0.06	N/A	$0.05	$86.32 million	$88.21 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
IRMD iRadimed	$0.68	1.20%	N/A	43.87%	1 Years
MDXG MiMedx Group	N/A	N/A	N/A	N/A	N/A
OFIX Orthofix Medical	N/A	N/A	N/A	N/A	N/A
SGHT Sight Sciences	N/A	N/A	N/A	N/A	N/A

Latest IRMD, OFIX, MDXG, and SGHT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/5/2025	IRMD iRadimed	quarterly	$0.17	1.3%	5/20/2025	5/20/2025	5/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IRMD iRadimed	N/A	8.87	7.62
MDXG MiMedx Group	0.09	4.70	4.13
OFIX Orthofix Medical	0.38	2.71	1.50
SGHT Sight Sciences	0.51	10.47	9.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IRMD iRadimed	92.34%
MDXG MiMedx Group	79.15%
OFIX Orthofix Medical	89.76%
SGHT Sight Sciences	55.51%

Insider Ownership

Company	Insider Ownership
IRMD iRadimed	36.80%
MDXG MiMedx Group	1.70%
OFIX Orthofix Medical	1.30%
SGHT Sight Sciences	30.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IRMD iRadimed	110	12.72 million	8.04 million	Optionable
MDXG MiMedx Group	870	147.70 million	145.19 million	Optionable
OFIX Orthofix Medical	1,616	39.18 million	38.67 million	Optionable
SGHT Sight Sciences	210	51.70 million	35.72 million	Optionable

IRMD, OFIX, MDXG, and SGHT Headlines

Recent News About These Companies

Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Rating of "Hold" by Brokerages

July 19 at 2:15 AM | marketbeat.com

Sight Sciences (NASDAQ:SGHT) Rating Lowered to Sell at Wall Street Zen

July 19 at 2:27 AM | americanbankingnews.com

Wall Street Zen Downgrades Sight Sciences (NASDAQ:SGHT) to Sell

July 19 at 2:25 AM | marketbeat.com

Morgan Stanley Increases Sight Sciences (NASDAQ:SGHT) Price Target to $4.00

July 17 at 2:37 AM | americanbankingnews.com

7SGHT : The Analyst Verdict: Sight Sciences In The Eyes Of 4...

July 15, 2025 | benzinga.com

Sight Sciences (NASDAQ:SGHT) Given New $4.00 Price Target at Morgan Stanley

July 15, 2025 | marketbeat.com

Sight Sciences, Inc. (NASDAQ:SGHT) CEO Paul Badawi Sells 23,637 Shares

July 9, 2025 | americanbankingnews.com

Sight Sciences, Inc. (NASDAQ:SGHT) Insider Matthew Link Sells 4,889 Shares

July 8, 2025 | insidertrades.com

Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells 4,889 Shares of Stock

July 7, 2025 | marketbeat.com

Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells $23,681.43 in Stock

July 7, 2025 | marketbeat.com

Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $38,197.20 in Stock

July 7, 2025 | marketbeat.com

Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CEO Sells 23,637 Shares of Stock

July 7, 2025 | marketbeat.com

SGHT - Sight Sciences Inc Chart - Morningstar

July 5, 2025 | morningstar.comM

Wall Street Zen Upgrades Sight Sciences (NASDAQ:SGHT) to "Hold"

June 28, 2025 | marketbeat.com

Sight Sciences Leads The Pack Of 3 Promising Penny Stocks

June 24, 2025 | uk.finance.yahoo.com

Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of "Hold" by Brokerages

June 24, 2025 | marketbeat.com

sight sciences appoints new board member and holds annual meeting

June 7, 2025 | uk.investing.com

Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th

May 14, 2025 | globenewswire.com

Sight Sciences stock holds as Needham reiterates rating

May 11, 2025 | uk.investing.com

Sight Sciences, Inc. (SGHT) Q1 2025 Earnings Call Transcript

May 11, 2025 | seekingalpha.com

Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2025 Earnings Call Transcript

May 10, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRMD, OFIX, MDXG, and SGHT Company Descriptions

iRadimed NASDAQ:IRMD

$56.69 -0.76 (-1.32%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$56.52 -0.16 (-0.29%)

As of 07/18/2025 06:27 PM Eastern

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

MiMedx Group NASDAQ:MDXG

$6.42 -0.30 (-4.46%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$6.50 +0.08 (+1.26%)

As of 07/18/2025 07:55 PM Eastern

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Orthofix Medical NASDAQ:OFIX

$10.63 -0.22 (-2.03%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$10.64 +0.01 (+0.14%)

As of 07/18/2025 05:09 PM Eastern

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Sight Sciences NASDAQ:SGHT

$3.50 -0.04 (-1.13%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$3.50 +0.00 (+0.14%)

As of 07/18/2025 04:04 PM Eastern

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time